Gastroenterology News

During Irritable Bowel Syndrome Awareness Month, an advocacy group launched the #IBSDilemma campaign to focus on the unique challenges that individuals living with this common gastrointestinal disorder may encounter in daily life.

Daily low-dose aspirin “significantly reduced” hepatic fat quantity at 6 months compared with placebo among patients with metabolic dysfunction-associated steatotic liver disease, according to preliminary trial results published in JAMA.

The number one financial goal for most physicians is getting to a comfortable retirement on their own timeline and with the lifestyle they want.

A multivariable risk prediction model “may be useful” for prioritizing patients at highest risk for colorectal cancer and awaiting surveillance colonoscopy when demand for the procedure is high, according to research in Gastro Hep Advances.

Coffee consumption may reduce risk for colorectal cancer recurrence and all-cause mortality, according to research published in the International Journal of Cancer.

While the CDC estimated that excessive alcohol use contributed to approximately 178,000 U.S. deaths each year from 2020 to 2021, an emerging lifestyle trend may help counter those statistics in the years ahead.

The FDA has updated the label indication for Vemlidy 25 mg for the treatment of chronic hepatitis B virus with compensated liver disease, expanding the patient population to include children aged 6 years and older who weigh at least 25 kg.

According to published results, industry payment distributions may be skewed by the 0.1% of physicians in each specialty who were paid more than $1 million from 2013 to 2022.

Incidence rates of distant and regional stage colorectal adenocarcinoma have increased over the past two decades among those aged 46 to 49 years and should be considered when counseling patients on screening initiation, research showed.

Once-daily Rinvoq 45 mg provided “rapid relief” of stool frequency and abdominal pain score within the first week of induction therapy in patients with moderately to severely active Crohn’s disease, according to a data analysis.